Nevertheless, EGCG has been demonstrated to play a potential role in human colon cancer prevention inhibiting AP-1, c-fos, cyclin D1 promoters, and NF-κB activity in four different human colon cancer cell lines, with an IC50 value of about 20 μg/mL [74]. The gene discussed is FOS; the disease is colonic neoplasm.